Reversible dissociation of a tumor-cell surface protease-inhibitor complex

F Steven1, M Griffin, D Blakey

  • 1ICI PLC,PHARMACEUT,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND.

Insights

Researchers identified a tumour cell surface protease (GB) and a cytoplasmic inhibitor. The enzyme-inhibitor complex can be dissociated and visualized using fluorescence microscopy and a specific probe.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Tumour cells exhibit a unique cell surface protease, designated GB.
  • A cytoplasmic inhibitor protein, derived from cultured tumour cells, can recognize and bind to this GB protease.

Purpose of the Study:

  • To investigate the interaction between tumour cell surface protease (GB) and its cytoplasmic inhibitor.
  • To explore methods for visualizing and confirming the recognition and inhibition of GB in tumour tissues.

Main Methods:

  • Utilized frozen tumour tissue sections to isolate cells with active GB.
  • Employed fluorescence microscopy with 9-amino acridine as a competitive fluorescent probe.
  • Investigated the reversible dissociation of the GB-inhibitor complex using sodium dodecyl sulphate.

Main Results:

  • Successfully demonstrated the recognition and inhibition of tumour cell surface protease (GB) by the cytoplasmic inhibitor.
  • Confirmed the reversible dissociation of the enzyme-inhibitor complex.
  • Visualized the interaction and inhibition process using fluorescence microscopy.

Conclusions:

  • The study confirms the existence and interaction of a specific protease (GB) and inhibitor on tumour cells.
  • Fluorescence microscopy with competitive probes offers a viable method for studying these interactions in situ.
  • Understanding these molecular interactions may offer new avenues for cancer research and therapeutic strategies.